MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0019856
Unifranco Life Sciences Pvt Ltd - pharma in Andhra Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹7.29 Cr
▼ 12% YoY
Net profit · FY 2023
₹74.48 Lakh
Net margin 10.2%
EBITDA · FY 2023
₹96.37 Lakh
EBITDA margin 13.2%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Open charges
₹4.8 Cr
Secured borrowings
Company age
20 yrs
Est. 2006
Directors on board
2
As per MCA filings
About Unifranco Life Sciences Pvt Ltd
Data last updated:
Unifranco Life Sciences Pvt Ltd is a private limited company based in Andhra Pradesh, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 16 February 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2006PTC049181. Its GSTIN is 36AAACU8109P1ZU (Telangana).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Narsin Surender and Narsin Akash.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unifranco Life Sciences Pvt Ltd D, Andhra Pradesh, India.
As per the financials filed for FY 2023, the company reported a revenue of ₹7.29 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹74.48 Lakh (net margin 10.2%) and EBITDA of ₹96.37 Lakh (EBITDA margin 13.2%). Revenue has grown at a compounded annual rate (CAGR) of 30% over five years.
As per MCA filings, the company has open charges of ₹4.8 Cr on record.
Unifranco Life Sciences Pvt Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0019856). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website uifranco.com.
Company details
CIN U24239TG2006PTC049181
Registration Number 049181
Incorporation Date 16 February 2006
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0019856
CIN history
Unifranco Life Sciences has one previous CIN (Corporate Identification Number): U24239AP2006PTC049181. The current CIN is U24239TG2006PTC049181, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2006PTC049181 | Current |
| U24239AP2006PTC049181 | Previous |
Key People
Narsin Surender Director Narsin Akash Director Recognitions & Rankings of Unifranco Life Sciences
Contact details
Unifranco Life Sciences Pvt Ltd's registered office is in Andhra Pradesh.
- Registered AddressUnifranco Life Sciences Pvt Ltd D, Andhra Pradesh, India
- IndustryPharma, Pharma Contract R&D
Comprehensive company report
Unifranco Life Sciences Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Unifranco Life Sciences Pvt Ltd
FY 2025 filings availableUnifranco Life Sciences Pvt Ltd reported revenue of ₹7.29 Cr (down 12% YoY) for FY 2023.
Revenue · FY 2023
₹7.29 Cr ▼ 12%
Net profit · FY 2023
₹74.48 Lakh margin 10.2%
EBITDA · FY 2023
₹96.37 Lakh margin 13.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 12%
5 years · compounded
▲ 30%
EBITDA CAGR growth
1 year
▲ 24%
5 years · compounded
▲ 58%
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 30%. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹7.29 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹96.37 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹74.48 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.2% | ||||
| Net Profit Margin | 10.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unifranco Life Sciences Pvt Ltd, buy the company report.
Board of directors of Unifranco Life Sciences Pvt Ltd
Unifranco Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narsin Surender | Director | 16 Feb 2006 | 20 Years 8 Months | Current |
| Narsin Akash Also directs: Stride Organics Private Limited | Director | 05 May 2022 | 4 Years 5 Months | Current |
Charges & borrowings
Open charges
₹4.8 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Mar 2023 | 100700026 | Idbi Bank Limited | ₹4.8 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Unifranco Life Sciences Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unifranco Life Sciences Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unifranco Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACU8109P1ZU | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Unifranco Life Sciences Pvt Ltd, buy the company report.
Recent activity
Unifranco Life Sciences Pvt Ltd has 4 board changes on record since 2006: 2 appointments and 2 cessations. The latest: Narsin Bhavani ceased to be Director on 11 Jul 2023.
AGM
Unifranco Life Sciences Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Unifranco Life Sciences Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Narsin Bhavani ceased to be Director.
Charges
A charge with Idbi Bank Limited amounted to Rs. 480.00 Lakh with Charge ID 100700026 was registered on 23 Mar 2023.
Ceased
Narsin Akash ceased to be Additional Director.
Appointed
Narsin Akash was appointed as Director.
Appointed
Narsin Surender was appointed as Director.
Incorporation
16 Feb 2006
Unifranco Life Sciences Pvt Ltd was registered on 16 Feb 2006 with Roc Hyderabad & aged 20 years 8 months as per MCA records.
Frequently asked questions
Unifranco Life Sciences is an active private limited company based in Andhra Pradesh, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 16 February 2006 (20+ years old) and is registered under CIN U24239TG2006PTC049181.
Unifranco Life Sciences has 2 current directors:
- Narsin Surender - Director
- Narsin Akash - Director
The latest financial statements of Unifranco Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Unifranco Life Sciences is 36AAACU8109P1ZU, registered in Telangana.
The CIN (Corporate Identification Number) of Unifranco Life Sciences is U24239TG2006PTC049181. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unifranco Life Sciences was incorporated on 16 February 2006, making it 20+ years old. It is registered with the Registrar of Companies, Hyderabad.
Narsin Bhavani ceased to be Director on 11 Jul 2023. Narsin Akash ceased to be Additional Director on 30 Sep 2022. Narsin Akash was appointed as Director on 05 May 2022. Unifranco Life Sciences has 4 board changes on record in total.
Yes, Unifranco Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0019856).
Unifranco Life Sciences can be reached through the website uifranco.com. Its registered office is in Andhra Pradesh, India.
The registered office of Unifranco Life Sciences is at Unifranco Life Sciences D, Andhra Pradesh, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages